3
Table 3. Sequential one-pot operation for synthesis of tetrahydro-
naphthyridines (5).a,b
Reaction conditions: aAll reactions were carried out on a 0.5 mmol of 2-
chloro-quinoline-3-ylmethyl)aryl amines (1 eq.), corresponding allylbromides
(1 eq.), Cs2CO3 (1.5 eq.) in DMF (5 mL). After 15 h, added Pd(OAc)2 (5
Scheme 4: Plausible mechanism
b
Conclusions
mol%), PPh3(10 mol%), and Cs2CO3 (2 eq.); Isolated yields after column
chromatography. c After 1 h added further 5 mol% of Pd(OAc)2.
In summary, we have successfully developed a sequential one-
pot approach for the synthesis of benzo[b][1,6]naphthyridine
derivatives from the 2-chloro-3-formyl quinolines via reductive
amination followed by N-allylation and intramolecular Heck-type
cyclization. The developed methodology is operationally simple,
step-economical and efficient for synthesis of 1,6-naphthyridine
derivatives. The generality and ready availability of the starting
materials should make this an attractive method for the synthesis
of biologically important benzo-naphthyridine motifs.
With a view to understand the generality, we next explored
reaction of 2a with acryloyl chloride for the synthesis of
benzo[b][1,6]naphthyrid-3-one (6). Unfortunately, desired
product (6) did not formed under the standard reaction
conditions (Scheme 3). Further, we have also tried to get (6)
in step-wise manner, but we could not succeed in getting the
amide itself. We also extended the reaction to methallyl
bromide to get the corresponding cyclised product (7) via 7-
endo-trig cyclisation, but at the end of the sequential one pot
reaction we could recover only the corresponding N-
allylated product.
Acknowledgments
We thank UPE-FAR and OUDST-PURSE program for the
financial assistance. PBKR thanks CSIR, New Delhi and KR and
KM thank UGC, New Delhi for their fellowship. We also thank
Department of Chemistry, OU for laboratory infrastructure under
SAP (DRS-I) and DST-FIST programmes.
References and notes
1.
2.
3.
(a) Yu, H.-B.; Yang, F.; Sun, F.; Ma, G.-Y.; Gan, J.-H.; Hu,
W.-Z.; Han, B.-N.; Jiao, W.-H.; Lin, H.-W.J. Nat. Prod., 2014,
77, 2124; (b) Pham, C.-D.; Hartmann, R.; Müller, W. E. G.;
Voogd, N. D. ; Lai , D.; Proksch, P. J. Nat. Prod., 2013, 76, 103;
(c) Liu, C.; Tang, X.; Li , P.; Li, G.Org. Lett., 2012,14, 1994.
(a) Srivastava, S. K.; Jaggi, M.; Singh, A.T.; Madan, A.; Rani, N.;
Scheme 3: Synthesis of tetrahydronaphthyridine derivative (6 and 7).
Based on the literature precedence,22 a plausible mechanism for
the Pd(0)-catalyzed intramolecular Heck cyclization of allyl-
benzyl-(2- chloro-quinoline-3yl-methyl)-amine (3a) to benzo[b]-
[1,6]napthyridines (4a) is given in Scheme 4. The first step in
catalytic cycle is the oxidative addition of 3a with Pd(0) species
to form quinoline-palladium intermediate (A). Intermediate (A)
then coordinates intramolecularly with double bond resulting in
complex (B) followed by the insertion of double bond to give
cyclized palladium intermediate (C), which further undergoes
elimination of -hydrogen to yield complex (D). Subsequent
Vishnoi, M.; Agarwal, S.K.; Mukherjee, R.;
Burman, A.
C.Bioorg. Med. Chem. Lett., 2007, 17, 6660;(b)Insuasty, B.;
Becerra, D.; Quiroga, J.; Abonia, R.; Nogueras, M.; Cobo. J.
Eur.J. Med. Chem.,2013, 60,1.
(a)Gangjee, A.; Zeng, Y.; McGuire, J. J.; Kisliuk, R. L. J. Med.
Chem.,2002, 45, 5173; (b) Tsuzuki, Y.; Tomita, K.; Sato,Y.;
Kashimoto, S.; Chiba, K., Bioorg. Med. Chem. Lett., 2004, 14,
3189.
Johns, B. A.; Weatherhead, J. G.; Allen, S. H.; Thompson, J. B.;
Garvey, E. P.; Foster, S. A.; Jeffrey, J. L.; Miller, W. H. Bioorg.
Med. Chem. Lett.,2009, 19, 1802.
Bernardino, A. M. R.; Castro, H. C.; Frugulhetti, I. C. P. P.;
Loureiro, N. I.V.;Azevedo, A.R.; Pi nheiro, L. C. S.; Souza, T. M.
L.; Giongo, V.; Passamani, F.;Magalhaes, U. O.; Albuquerque, M.
G.; Cabral, L. M.; Rodrigues, C. R. Bioorg. Med. Chem., 2008, 16,
313.
4.
5.
dissociation of
D
furnished the product 4a and
hydridopalladium(II) halide, which undergoes reductive
elimination to regenerate the active Pd(0) complex.
6.
7.
Ferrarini, P. L.; Manera, C.; Mori, C.; Badawneh, M.;
Saccomanni, G. Farmaco, 1998, 53,741.
Zeng, L.-F.; Wang, Y.; Kazemi, R.; Xu, S.; Xu, Z.-L.; Sanchez, T.
W.; Yang, L.-M.;Debnath, B.; Odde, S.; Xie, H.; Zheng, Y.-T.;
Ding, J.; Neamati, N.; Long, Y.-Q, J. Med. Chem.,2012, 55, 9492.